Side Effects Pneumonia Vaccine

Know what side effects pneumonia vaccine is. More than 90 different types of pneumococci are known, 23 of which are responsible for more than 90% of the diseases. Approximately half of the population is germs, the bacteria usually do not cause disease in the healthy human being. In small children, the elderly, chronically ill persons and persons with a weakened immune system, pneumococci can lead to dangerous inflammation.

Pneumococci cause – especially in small children – inflammation of the middle ear. The bacteria can also extend from the middle ear to neighboring structures; A particularly feared complication is the purulent pneumococcal meningitis (meningitis), in which 60-80% of patients die.

Meningitis may also occur as the sole manifestation of a pneumococcal infection or as a result of pneumonia. The latter affects mainly the elderly. Often a whole lung lobe is affected; one feels seriously ill, has difficulty breathing and high fever. Also the rib fur and the heart bag can be affected. If the bacteria are flooded into the bloodstream, dangerous blood poisoning (sepsis) can occur.

A pneumococcal infection can be so rapid and aggressive that the patient’s death can not be prevented even by intensive medical measures.

Side Effects Pneumonia Vaccine

What’s Side Effects Pneumonia Vaccine?

Who should be vaccinated against pneumococci?

Pneumococcal disease is one of the most frequent and severe infectious diseases. Vaccination is generally recommended for all infants from the 3rd month of life. In addition, there are certain groups of people who are at increased risk of pneumococcal infection or who may experience severe forms of infection in case of infection. These include in particular:

  • People over 50 years
  • Infants and children with delayed development (failure to thrive)
  • Persons with certain chronic diseases, e.g. Cancer, cardiovascular disease, respiratory system diseases such as
  • asthma or COPD, diabetes mellitus, liver cirrhosis

The highest risk for pneumococcal infection is the following groups of persons (high-risk groups):

  • Persons with diseases of the blood-forming organs
  • Persons with congenital or acquired immune deficiencies (such as HIV infection)
  • Persons with asplenia (i.e., missing or malfunctioning spleen), or e.g. also Sichelkw√§√§mie
  • Persons with a cochlear implant (hearing prosthesis)
  • Persons with a cerebrospinal fluid (a diseased connection between the brain and spinal fluid spaces)
  • Persons after loss of CSF (e.g., as a result of injury)
  • Persons before or after an organ transplant or after stem cell transplantation or during an immunosuppressive therapy
  • Children with disorders of the nervous system, e.g. epilepsy
  • Persons with nephrotic syndrome or chronic renal insufficiency

For persons from a high-risk group, special care should be taken to ensure adequate vaccination protection.

Although the bacterium Streptococcus pneumoniae can be controlled by means of antibiotics, their use sometimes comes too late. Apart from this, an increasing number of antibiotic-resistant pneumococci are developing.

Pneumococcal disease (pneumonia, pneumonia, pneumonia, pneumonia, pneumonia, pneumonia, pneumonia, Pneumococcal vaccination, on the other hand, produces immunity to 10, 13 and 23 strains depending on the vaccine.

What causes the vaccination in the body?

Pneumococcal vaccination contains non-proliferative components of the pathogen which are necessary for triggering an immune response. More specifically, these are capsular polysaccharides – these are characteristic surface structures of the bacterium. The pneumococcal vaccine is a dead vaccine.

After vaccination, the human body produces defenses (so-called antibodies) against the bacterium, an active immunization occurs. If a vaccine is applied by droplet infection with pneumococci, these are trapped by the antibodies. This prevents an outbreak of pneumococcal diseases.

The immune system of small children is not able to react adequately to the capsular polysaccharides in vaccination. Therefore, the original (unconjugated) vaccine is not suitable at this age. By using a technology that connects the vaccine to a certain substance, the conjugate is called “conjugated”, the response of the immune system can be improved in small children. An effective vaccination is also available for infants.

You may also like